Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117567441A reveals novel anti-inflammatory synthesis. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN117586274B reveals novel forskolin ring-expansion synthesis. Offers high-purity intermediates with streamlined scalability for global pharmaceutical supply chains.
Patent CN110669020A reveals efficient Cyclen production. Reduces cost and improves supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN102766023A reveals a novel two-step route avoiding azeotropes, offering cost reduction in fluorochemical manufacturing and reliable supply chain solutions.
Patent CN101007793A reveals optimized EHATA synthesis reducing waste. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Novel toluene-based Kolbe-Schmitt process yields >99.5% purity antioxidant intermediate with superior safety and cost efficiency for industrial scale-up.
Novel UIO-66 solid acid catalyst method for high-purity R-2-chloropropionic acid. Reduces waste and improves supply chain reliability for pharmaceutical intermediates.
Discover efficient chromone-based routes for high-purity pyrimidine derivatives. Enhance your antiviral pipeline with scalable, cost-effective pharmaceutical intermediates.
Patent CN101343306B reveals a low-cost synthesis for 6,7-methylene steroids using dibromomethane, offering significant supply chain advantages for Drospirenone manufacturers.
Patent CN101343306B reveals a low-cost synthesis for 6,7-methylene steroids using dibromomethane. Ideal for Drospirenone intermediates with reduced production costs.
Patent CN110845424A reveals water-based synthesis for 5-acetoacetylaminobenzimidazolone. Achieve higher yield and reduced environmental impact for reliable supply.
Novel patent CN103664960B details metal-free Ponatinib synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107033124B details a streamlined Alectinib route reducing purification steps. This offers supply chain stability and cost efficiency for global pharmaceutical manufacturing partners.
Novel spiro-containing dihydropyrimidine derivatives with antitumor activity. Efficient synthesis route offers cost reduction and scalability for pharmaceutical intermediates.
Novel patent CN108658931A offers high-yield route for Raltitrexed intermediate. Reduces toxic waste and ensures supply chain stability for pharmaceutical manufacturing.
Patent CN112521348B details a green route for epoxysuccinic acid using titanium silicalite, eliminating heavy metals and reducing costs for water treatment and pharma sectors.
Patent CN101786983A reveals a mild one-pot synthesis for 2-amino-1,2-dihydroisoquinolines using AgOTF and NHC catalysts, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN104262167B reveals a mild metal phthalocyanine catalytic route for diarylamines, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN117362311A reveals novel forskolin analogue synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN118056823A reveals a scalable route for high-purity Platinib intermediates. This process eliminates chromatography, ensuring cost reduction and supply reliability for pharmaceutical manufacturers.